Brand Engagement Network Inc
Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Feb 14, 2025
Contents
Cover page
Show cover page
As filed with the Securities and Exchange Commission on February 14, 2025.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORMS-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
(Exact name of registrant as specified in its charter)
| Delaware | 7372 | 98-1574798 |
|---|---|---|
| (State or other Jurisdiction of Incorporation Or Organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
145 E. Snow King Ave
PO Box 1045
Jackson, WY 83001
(307) 757-3650
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Paul Chang
145 E. Snow King Ave
PO Box 1045
Jackson, WY 83001
(307) 757-3650
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)
Copies of all communications, including communications sent to agent for service, should be sent to:
Matthew L. Fry, Esq.
Haynes and Boone, LLP
2801 N. Harwood St.
Suite 2300
Dallas, Texas 75201
(214) 651-5000
Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.☐
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED FEBRUARY 14, 2025
PRELIMINARY PROSPECTUS
UP TO SHARES OF COMMON STOCK
PRE-FUNDED WARRANTS TO PURCHASE UP TO SHARES OF COMMON STOCK
UP TO SHARES OF COMMON STOCK UNDERLYING THE PRE-FUNDED WARRANTS
COMMON WARRANTS TO PURCHASE UP TO SHARES OF COMMON STOCK
UP TO SHARES OF COMMON STOCK UNDERLYING THE COMMON WARRANTS
PLACEMENT AGENT WARRANTS TO PURCHASE UP TO SHARES OF COMMON STOCK
UP TO SHARES OF COMMON STOCK UNDERLYING THE PLACEMENT AGENT WARRANTS
This is a best efforts public offering of up to shares of our common stock, par value $0.0001 per share (the “Common Stock”), together with warrants to purchase up to an aggregate of shares of our Common Stock (the “Common Warrants”) at an assumed combined public offering price of $ per share and one Common Warrant (the last reported sale price per share of our Common Stock on the Nasdaq Capital Market on , 2025). We are also offering pre-funded warrants to purchase up to shares of our Common Stock (the “Pre-Funded Warrants”) and the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants, in lieu of shares of Common Stock, to those investors whose purchase of shares of our Common Stock in this offering would result in the investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the investor, 9.99%) of our outstanding Common Stock immediately following the consummation of this offering. Each Pre-Funded Warrant will be exercisable for one share of our Common Stock. Each Pre-Funded Warrant is being sold together with one Common Warrant. Each Pre-Funded Warrant and the accompanying Common Warrant will be offered at an offering price equal to the combined public offering price at which a share of Common Stock and accompanying Common Warrant is being offered, minus $0.0001. The exercise price of the Pre-Funded Warrants will be $0.0001 per share, and the Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Warrant we sell, the number of shares of Common Stock we are offering will be decreased on a one-for-one basis. The number of Common Warrants sold in this offering will not change as a result of a change in the mix of the shares of our Common Stock and Pre-Funded Warrants sold. The exercise price of the Common Warrants will be $ per share. The Common Warrants will be exercisable immediately on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the “Warrant Stockholder Approval Date” and such approval, the “Warrant Stockholder Approval”); provided, however, that, if and only if the Pricing Conditions (as defined below) are met, the Common Warrants will be exercisable upon issuance. As used herein “Pricing Conditions” means that the combined offering price per share and accompanying Common Warrant is such that the Warrant Stockholder Approval is not required under the rules of the Nasdaq Stock Market LLC (“Nasdaq”) because either (i) the offering is an at-the-market offering under the rules of the Nasdaq and such price equals or exceeds the sum of (a) the applicable “Minimum Price” per share under Nasdaq Rule 5635(d) plus (b) $0.125 per whole share of Common Stock underlying the Common Warrants or (ii) the offering is a discounted offering where the pricing and discount (including attributing a value of $0.125 per whole share underlying the Common Warrants) meet the pricing requirements under the Nasdaq’s rules. The Common Warrants will expire five years from the Warrant Stockholder Approval Date, provided that if the Pricing Conditions are met, the Warrants will expire five years from the date of issuance. This offering also relates to the shares of Common Stock issuable upon the exercise of any Pre-Funded Warrants and any Common Warrants. The shares of Common Stock and Pre-Funded Warrants, as the case may be, and the accompanying Common Warrant, can only be purchased together in this offering but will be issued separately and will be immediately separable upon issuance.
Our Common Stock is listed on The Nasdaq Capital Market under the symbol “BNAI,” and our warrants to purchase Common Stock (the “Public Warrants”) are listed on The Nasdaq Capital Market under the symbol “BNAIW”. On February 13, 2025, the last reported sales price of the Common Stock was $0.6621 per share, and the last reported sales price of our Public Warrants was $0.043 per Public Warrant. We are an “emerging growth company” and a “smaller reporting company” as defined under the U.S. federal securities laws and, as such, may elect to comply with certain reduced public company reporting requirements for this and future filings. All share, Pre-Funded Warrant and Common Warrant numbers are based on an assumed combined public offering price of $ per share and accompanying Common Warrant (or $ per Pre-Funded Warrant and accompanying Common Warrant). The actual public offering price per share of Common Stock and accompanying Common Warrant and per Pre-Funded Warrant and accompanying Common Warrant, as the case may be, will be determined between us, the Placement Agent (as defined below) and the investors at the time of pricing, may be at a discount to the current market price, and may be based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present operating results, the previous experience of our executive officers and the general condition of the securities markets at the time of this offering. Therefore, the assumed combined public offering price used throughout this prospectus may not be indicative of the final offering price. There is no established public trading market for the Pre-Funded Warrants or the Common Warrants, and we do not expect a market to develop. In addition, we do not intend to list the Pre-Funded Warrants or the Common Warrants on the Nasdaq Capital Market, any other national securities exchange or any other nationally recognized trading system.
This offering will terminate on , 2025, unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. We will have one closing for all securities purchased in this offering and the combined public offering price per share of Common Stock (or Pre-Funded Warrant) and accompanying Common Warrant will be fixed for the duration of this offering.
We have engaged as our exclusive placement agent (the “Placement Agent”) to use its reasonable best efforts to solicit offers to purchase our securities in this offering. The Placement Agent has no obligation to purchase any of the securities from us or to arrange for the purchase or sale of any specific number or dollar amount of the securities. Because there is no minimum offering amount required as a condition to closing in this offering the actual public offering amount, Placement Agent’s fee, and proceeds to us, if any, are not presently determinable and may be substantially less than the total maximum offering amounts set forth above and throughout this prospectus. In addition, because there is no escrow trust or similar arrangement and no minimum offering amount, investors could be in a position where they have invested in our company, but we are unable to fulfill all of our contemplated objectives due to a lack of interest in this offering. We have agreed to pay the Placement Agent the Placement Agent fees set forth in the table below. See “Plan of Distribution” in this prospectus for more information. Because there is no minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to pursue our business goals described in this prospectus. We will bear all costs associated with the offering.
| Per Pre- | |||||
| Funded | |||||
| Per Share and | Warrant and | ||||
| Accompanying | Accompanying | ||||
| Common | Common | ||||
| Warrant | Warrant | Total | |||
| Public offering price | $ | $ | $ | ||
|---|---|---|---|---|---|
| Placement Agent fees (1) | $ | $ | $ | ||
| Proceeds, before expenses, to us (2) | $ | $ | $ | ||
| (1) | Represents a cash fee equal to 6.5% of the aggregate purchase price paid by investors in this offering. In addition, we have agreed to reimburse the Placement Agent for certain expenses. In addition, we have agreed to issue the placement agent or its designees, as compensation in connection with this offering, warrants (the “Placement Agent Warrants”), to purchase a number of shares of Common Stock equal to 6.5% of the shares of Common Stock sold in this offering (including the shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants), at an exercise price of $ per share, which represents 125% of the combined public offering price per share of Common Stock and accompanying Common Warrant. See “Plan of Distribution” on page 126 of this prospectus for more information. |
| (2) | Because there is no minimum number of securities or amount of proceeds required as a condition to closing in this offering, the actual public offering amount, placement agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less than the total maximum offering amounts set forth above. The amount of the offering proceeds to us presented in this table does not give effect to the exercise, if any, of the Pre-Funded Warrants or the Common Warrants. |
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 17 to read about factors you should consider before investing in shares of our Common Stock.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
Delivery of the shares of Common Stock, Pre-Funded Warrants and Common Warrants offered hereby is expected to take place on , 2025, subject to satisfaction of certain conditions.
The date of this prospectus is , 2025
TABLE OF CONTENTS
| ABOUT THIS PROSPECTUS | ii |
|---|---|
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | iii |
| PROSPECTUS SUMMARY | 1 |
| RISK FACTORS | 17 |
| USE OF PROCEEDS | 51 |
| DILUTION | 52 |
| MARKET INFORMATION FOR COMMON STOCK AND DIVIDEND POLICY | 53 |
| MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 54 |
| BUSINESS | 73 |
| DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE | 85 |
| EXECUTIVE COMPENSATION | 92 |
| CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, AND DIRECTOR INDEPENDENCE | 107 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS | 110 |
| DESCRIPTION OF SECURITIES | 111 |
| DESCRIPTION OF SECURITIES WE ARE OFFERING | 123 |
| PLAN OF DISTRIBUTION | 126 |
| LEGAL MATTERS | 129 |
| CHANGE IN ACCOUNTANTS | 129 |
| EXPERTS | 129 |
| WHERE YOU CAN FIND ADDITIONAL INFORMATION | 129 |
| INDEX TO FINANCIAL STATEMENTS | F-1 |
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.